Participants: Patients undergoing cardiac surgery without contraindications to aprotinin administration.
Six healthy adults without contraindications to transcranial magnetic stimulation (TMS) participated in the study.
Conclusions: Scandinavian gynecologists are generally well informed concerning HRT and liberally recommend HRT for women without contraindications.
In Norway and Sweden, the proportion of gynecologists routinely prescribing HRT for women without contraindications increased with age and in the oldest age group of gynecologists (>55 years) 49 and 56%, respectively, recommended HRT to all women.
Care metrics include only patients documented to be eligible and without contraindications or intolerance.
BACKGROUND: Postdischarge adherence and long-term persistence in the use of warfarin among patients with heart failure and atrial fibrillation without contraindications have not been fully described.
Among patients without contraindications, most appeared to be eligible for any anticoagulant, and relatively high-risk features appeared not to influence warfarin use.
The proportions of patients with documented contraindications to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers as well as the use of these medications among patients without contraindications at hospital discharge was determined across levels of risk.
Although industry guidelines do not require anticoagulation with IABP, especially at a 1 1 ratio, heparin use with IABP in patients without contraindications, maintained >24 h, and with a lower ratio (e.g., 1 2) is thought to be reasonable [8].
To reduce bowel peristalsis, patients without contraindications received 40 mg N-butyl-scopolamine intravenously (Buscopan; Boehringer, Ingelheim, Germany) in 100 mL 0.9% NaCl continuously during the examination as drip infusion.
A total of 111 consecutive patients (28 women, mean age 63±8 years) with suspected coronary disease and without contraindications to MSCT, MRI, and Angio were prospectively included and underwent all three tests as part of the protocol of an investigator-initiated study on noninvasive coronary angiography [15].
